DelveInsight’s, “Degenerative Disc Disease - Pipeline Insights, 2017”, report provides comprehensive insights about pipeline drugs across this indication. This report further provides information on the therapeutic development of more than 10+ pipeline drugs at various stages covering Phase II, Phase I, Pre-clinical and Discovery therapeutics and contains a comparative assessment by monotherapy, route of administration and molecule type. The report further features the dormant products for this indication. Leading companies in this space are Bone Therapeutics, Yuhan Corporation, BioRestorative Therapies and AnGes,.
Comparative analysis of pipeline drugs at various stages and their therapeutic assessment by product type and molecule type provides additional and vital details of the pipeline drugs. Information on various technologies involved in the development of pipeline therapeutics along with all the collaborations and agreements of the respective company brings added the advantage of this report. Patent and Financing details related to the products are also provided.
The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.
Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.